The international study of insulin and cancer.

Grimaldi-Bensouda, L; Marty, M; Pollak, M; Cameron, D; Riddle, M; Charbonnel, B; Barnett, A H; Boffetta, P; Boivin, J F; Evans, M; Rossignol, M; Benichou, J; Abenhaim, L

Grimaldi-Bensouda, L; Marty, M; Pollak, M; Cameron, D; Riddle, M; Charbonnel, B; Barnett, A H; Boffetta, P; Boivin, J F; Evans, M; Rossignol, M; Benichou, J; Abenhaim, L.

Lancet ; 376(9743): 769-70, 2010 Sep 04.

Article in En | MEDLINE | ID: mdl-20816540

Subject(s)

Breast Neoplasms/chemically induced; Hypoglycemic Agents/adverse effects; Insulin/adverse effects; Breast Neoplasms/prevention & control; Canada; Case-Control Studies; Confounding Factors, Epidemiologic; Diabetes Mellitus/drug therapy; Female; France; Humans; Hypoglycemic Agents/administration & dosage; Insulin/administration & dosage; Insulin/analogs & derivatives; Insulin Glargine; Insulin, Long-Acting; International Cooperation; Multicenter Studies as Topic; Risk Factors; United Kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Hypoglycemic Agents / Insulin Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Female / Humans Country/Region as subject: America do norte / Europa Language: En Journal: Lancet Year: 2010 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google